December 29, 2024
NineSigma’s client is a leading global pharmaceutical company at the forefront of state-of-the-art biopharmaceutical research and innovation. As part of their innovation pursuits, they are launching a novel new treatment for Psoriasis, a chronic autoimmune disease that impacts over 125 million individuals globally. Psoriasis is characterized by red, scaly patches of […]
